Bioequivalence Test of Hemay005 Tablets

• Status: COMPLETED
• Trial end date: 2025-02-17

Summary

The pharmacokinetics behavior of the test formulation T1 and the control formulation T2 were evaluated by oral administration in healthy subjects under fasting state to evaluate the bioequivalence of the two formulations.

• Phase: PHASE1

Details

• Lead Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd
• Treatments: Hemay005